DOI QR코드

DOI QR Code

Prostate spindle cell neoplasm associated with early voiding difficulty after transurethral resection of the prostate

  • Chang Lim Hyun (Department of Pathology, Jeju National University College of Medicine) ;
  • Jung Sik Huh (Department of Urology, Jeju National University College of Medicine) ;
  • Kyung Kgi Park (Department of Urology, Jeju National University College of Medicine)
  • Received : 2023.01.03
  • Accepted : 2023.02.21
  • Published : 2023.06.30

Abstract

This report presents the case of 75-year-old men with spindle cell neoplasm. The patient underwent percutaneous nephrolithotomy and transurethral resection of the prostate (TURP) for renal stones and benign prostatic hyperplasia. One month postoperatively, the patient was able to void without any difficulty. Five months later, the patient experienced difficulty voiding and presented to the emergency room with severe pelvic pain. Computed tomography (CT) showed regrowth of the prostate mass into the posterior bladder and penile root. The prostate-specific antigen level remained constant at 1.14 ng/mL during the pre-and postoperative periods. Five months before the TURP operation, the patient's CT scan showed a soft and mildly enlarged prostate with no protrusion into the bladder. Biopsy of the prostate, however, showed a protruding mass, indicative of a spindle cell neoplasm. The patient was subsequently treated with the chemotherapeutic drug adriamycin. Unfortunately, treatment was unsuccessful, and the patient died 18 months later.

Keywords

References

  1. Lepor H. Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol 2004;6(Suppl 9):S3-10.
  2. Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology 2003;61:267-73. https://doi.org/10.1016/S0090-4295(02)02371-3
  3. Parsons JK, Dahm P, Kohler TS, Lerner LB, Wilt TJ. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol 2020;204:799-804. https://doi.org/10.1097/JU.0000000000001298
  4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
  5. Schuster GA, Schuster TG. The relative amount of epithelium, muscle, connective tissue and lumen in prostatic hyperplasia as a function of the mass of tissue resected. J Urol 1999;161:1168-73. https://doi.org/10.1016/S0022-5347(01)61620-3
  6. Wei J, Zheng X, Li L, Wei W, Long Z, He L. Rapid progression of mixed neuroendocrine carcinoma-acinar adenocarcinoma of the prostate: a case report. Oncol Lett 2016;12:1019-22. https://doi.org/10.3892/ol.2016.4737
  7. Guo Z, He J, Pan J, Huang L, Cao J, Bai Z, et al. Prevalence and risk factors for incidental prostate cancer in patients after transurethral resection of the prostate with negative results on prostate biopsy: a retrospective study. Investig Clin Urol 2022;63:201-6. https://doi.org/10.4111/icu.20210415
  8. Karlsson CT, Wiklund F, Gronberg H, Bergh A, Melin B. Risk of prostate cancer after trans urethral resection of BPH: a cohort and nested case-control study. Cancers (Basel) 2011;3:4127-38. https://doi.org/10.3390/cancers3044127
  9. Brockway WJ, Navetta A, Soni P, El Tayeb MM. Two cases of spindle cell neoplasms in patients undergoing holmium laser enucleation of the prostate. J Endourol Case Rep 2019;5:174-7. https://doi.org/10.1089/cren.2019.0048
  10. Farag M, Ta A, Shankar S, Wong LM. Secondary spindle cell sarcoma following external beam radiotherapy for prostate cancer: a rare but devastating complication. BMJ Case Rep 2018;2018:bcr2018225295.
  11. Choi SY, Ryu J, You D, Jeong IG, Hong JH, Ahn H, et al. Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study. J Cancer Res Clin Oncol 2018;144:751-8. https://doi.org/10.1007/s00432-018-2597-5